Publications Scientifiques

[ Article ] Interest of Prevention of Immediate Postpartum Hemorrhage with Misoprostol during Cesarean Section

Date de soumission: 17-02-2018
Année de Publication: 2016
Entité/Laboratoire Unité de Gynécologie Obstétrique
Document type : Article
Discipline(s) : Médécine de la reproduction ( Gynécologie, Andrologie, obstétique)
Titre Interest of Prevention of Immediate Postpartum Hemorrhage with Misoprostol during Cesarean Section
Auteurs VODOUHE MAHUBLO [1], TONATO EPSE BAGNAN JOSIANE ANGÉLINA ADJOUA [2], HOUNKPATIN BENJAMIN IGNACE BODOUNRIN [3], OBOSSOU Awadé Afoukou Achille [4], SIDI Imorou Rachidi [5], PERRIN RENÉ-XAVIER [6],
Journal: Clinics in Mother and Child Health
Catégorie Journal: Internationale
Impact factor: 0.35
Volume Journal: 13
DOI: 10.4172/2090-7214.1000250
Resume Objective: The purpose of this study was to compare the efficacy of sublingual misoprostol to oxytocin for the prevention of Immediate Postpartum Hemorrhage (IPPH) during caesarian section in the Borgou Regional University Teaching Hospital (CHUDB). Methods: It was a prospective randomized controlled clinical trial conducted over a period of 6 months from January 26 to July 26, 2015, on 230 female patients meeting inclusion criteria: cesarean section on term singleton pregnancy, under spinal anesthesia, without any bleeding. The patients were selected at random and divided into two groups: the first group had received 600 micrograms (μg) of misoprostol by sublingual route during umbilical cord clamping; the second one was administered 20 UI of oxytocin through intravenous route. The primary endpoint was drop in hematocrit. The secondary endpoints were drop in hemoglobin level, perioperative blood loss and postoperative complications. Findings: The socio-demographic and obstetrical characteristics of both groups’ patients were comparable. Average drop in hematocrit was identical: 0.05 ± 0.04 in both groups (p=0.573). The same applies to mean hemoglobin level: 1.7 ± 1.2 g/dl (p=0.886). As well, no significant difference was noted in average blood loss between the misoprostol group and the oxytocin group, respectively 281.8 ± 124.4 ml and 282.2 ± 120.8 ml (p=0.271). The incidence of side effects such as fevers and chills was significantly higher in the misoprostol group, respectively (79.1% vs. 9.6% and 79.1% vs. 0.0% p<0.001). However, those side effects were tolerable. Conclusion: 600 μg of misoprostol dose by sublingual route is also as effective as oxytocin in the prevention of postpartum hemorrhage without significant side effects.
Mots clés Cesarean section; Sublingual misoprostol; Prevention; Postpartum hemorrhage
Pages 1 - 5
Fichier (PDF)

Publications par entité

  • Centre de Formation et de Recherche en matière de Population (CEFORP) (15)
  • Centre Interfacultaire de Formation et de Recherche en Environnement pour le Développement Durable (CIFRED) (18)
  • Chaire Internationale en Physique Mathématique et Applications (CIPMA-Chaire UNESCO) (16)
  • Ecole Doctorale Pluridisciplinaire <<Espaces, Culture et Développement>> (0)
  • Ecole Nationale d'Administration et de Magistrature (ENAM) (47)
  • Ecole Nationle d'Economie Appliquée et de Management (80)
  • Ecole Normale Supérieure (24)
  • Ecole Polytechnique d'Abomey-Calavi (EPAC) (877)
  • Faculté de droit et de Science Politique (FADESP) (57)
  • Faculté des Lettres et Sciences Humaines (FLASH) (889)
  • Faculté des Lettres, Langues, Arts et Communications (FLLAC) (0)
  • Faculté des Sciences Agronomiques (1433)
  • Faculté des Sciences de la Santé (FSS) (1757)
  • Faculté des Sciences Economiques et de Gestion (FASEG) (144)
  • Faculté des Sciences et Techniques (FAST) (789)
  • Faculté des Sciences Humaines et Sociales (FASHS) (19)
  • Institut de Formation et de Recherche en Informatique (IFRI) (72)
  • Institut de Mathématiques et de Sciences Physiques (IMSP) (75)
  • Institut National de l'Eau (INE) (13)
  • INSTITUT NATIONAL DE LA JEUNESSE DE L’EDUCATION PHYSIQUE ET SPORT(INJEPS) (192)
  • Institut National des Métiers d'Art d'Archéologie et de la Culture (INMAAC) (4)
  • Institut National Médico Sanitaire ( INMeS) (0)
  • Institut Régional de Santé Publique (IRSP) (51)

Publications par sexe

  • Femme( 993 )
  • Homme (